Download App
PAPER TRADE
Download App
Login
Feedback
SUNPHARMA
newsbot
Reputation: 200,918 •
May 28, 2020 8:48 PM
Buy Sun Pharmaceuticals; target of Rs 530: Dolat Capital
Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 27, 2020.
Moneycontrol
https://www.moneycontrol.com/news/business/stocks/buy-sun...
#SUNPHARMA
Vote
Comment
Share
NSE:SUNPHARMA price when posted: 460.8